למיסיל דרמג'ל
Country: Israel
Language: Hebrew
Source: Ministry of Health
Patient Information leaflet
(PIL)
17-08-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TERBINAFINE
Available from:
GSK CONSUMER HEALTHCARE, ISRAEL LTD
ATC code:
D01BA02
Pharmaceutical form:
ג'ל
Composition:
TERBINAFINE 1 %
Administration route:
חיצוני
Prescription type:
אין צורך במרשם
Manufactured by:
GSK CONSUMER HEALTHCARE SCHWEIZ AG, SWITZERLAND
Therapeutic group:
TERBINAFINE
Therapeutic area:
TERBINAFINE
Therapeutic indications:
Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g.T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidemophyton floccosum. Pityriasis ( tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur).
Authorization date:
2014-12-31
Patient Information leaflet
Pharma code 1335
Gluing area
157.5 mm
11 mm
RECTO
72 mm
210 mm
9 mm
10 mm
10 mm
Order – AWF
Reference
Format
Pharma code
Colour
Font
Minimum font size
Reference MKT
Production site
Reference SITE
Pre-press
LAM DERM 15 G IL 150886_935689Z_PIL
Sonoco-Trident - TR1084632/2/DIS - 06/04/2016
AWF 24763 - OTDC 404578
1335
157.5x210 mm (2 leafes) - PN-P12-V6
NCH Nyon - CH
IL 150886
Proof
PANTONE Reflex Blue U
Outlined - approx 6.7 pt
Outlined
Z
- Recto/Verso
Read the complete document
